(Total Views: 644)
Posted On: 09/07/2020 3:01:49 PM
Post# of 154882
A one hour meeting is just ridiculous. I was sure I must have gotten that number wrong.
"Path to market" indeed.
They can't discuss anything in an hour.
About the only thing they can do is argue about how many doses CYDY can send to Britain for mild/moderates.
And the main issue there is: Don't waste doses on mild/moderate if severe/critical is going to be approved!
I would say that's about the ony thing they can discuss in an hour.
UK can ask if mild/moderate is approved, dose CYDY have any supply for mild/moderate in the event that severe/critical is approved.
"Path to market" indeed.
They can't discuss anything in an hour.
About the only thing they can do is argue about how many doses CYDY can send to Britain for mild/moderates.
And the main issue there is: Don't waste doses on mild/moderate if severe/critical is going to be approved!
I would say that's about the ony thing they can discuss in an hour.
UK can ask if mild/moderate is approved, dose CYDY have any supply for mild/moderate in the event that severe/critical is approved.
(1)
(1)
